Inventiva (IVEVF) EBITDA Margin Growth (1y) (2021)
Powered by 
Analysis
Inventiva (IVEVF) EBITDA Margin Growth (1y) (2021) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.95 Bn | 625.20 Bn | 17.26 Bn | 22.00 |
| 2 | AbbVie | 441.39 Bn | 434.82 Bn | 12.70 Bn | 613.00 |
| 3 | Merck | 366.72 Bn | 359.58 Bn | 12.21 Bn | -3,510.00 |
| 4 | Novartis Ag | 266.68 Bn | 258.99 Bn | 11.24 Bn | -164.00 |
| 5 | Pfizer | 159.20 Bn | 147.50 Bn | 10.94 Bn | -611.00 |
| 6 | Sanofi | 52.43 Bn | 45.05 Bn | 10.79 Bn | -572.00 |
| 7 | Revolution Medicines | 44.08 Bn | 44.08 Bn | - | - |
| 8 | Incyte | 25.50 Bn | 20.96 Bn | 1.57 Bn | -194.00 |
| 9 | United Therapeutics | 21.54 Bn | 18.88 Bn | 683.80 Mn | -341.00 |
| 10 | Inventiva | 693.72 Mn | 693.72 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2021 | -904,857.00 |
| Mar 31, 2021 | -561,330.00 |